| Income Statement |
| Total Revenue | 54.88M |
|
| Revenues (USD) | 54.88M |
| Cost of Revenue | 26.92M |
| Gross Profit | 27.96M |
| Operating Expenses | 45.39M |
| Research and Development Expense | 12.38M |
| Selling, General and Administrative Expense | 25.45M |
| Operating Income | -17.42M |
| Income Tax Expense | 217.00K |
| Net Income | -10.89M |
| Net Income Common Stock | -10.89M |
| Net Income Common Stock (USD) | -10.89M |
| Consolidated Income | -10.30M |
| Net Income to Non-Controlling Interests | 585.00K |
| Earnings per Basic Share | -0.66 |
| Earnings per Basic Share (USD) | -0.66 |
| Earnings per Diluted Share | -0.66 |
| Earning Before Interest & Taxes (EBIT) | -10.67M |
| Earning Before Interest & Taxes (USD) | -10.67M |
| Weighted Average Shares | 16.59M |
| Weighted Average Shares Diluted | 16.59M |
| Balance Sheet |
| Cash and Equivalents | 180.00M |
| Cash and Equivalents (USD) | 180.00M |
| Trade and Non-Trade Receivables | 57.09M |
| Current Assets | 259.05M |
| Property, Plant & Equipment Net | 178.00K |
| Total Assets | 325.97M |
| Debt Current | 3.96M |
| Total Debt | 3.96M |
| Current Liabilities | 83.77M |
| Total Liabilities | 85.85M |
| Accumulated Retained Earnings (Deficit) | -2.07B |
| Accumulated Other Comprehensive Income | -12.07M |
| Shareholders Equity | 227.33M |
| Shareholders Equity (USD) | 227.33M |
| Assets Non-Current | 66.92M |
| Total Debt (USD) | 3.96M |
| Deferred Revenue | 30.67M |
| Goodwill and Intangible Assets | 61.09M |
| Inventory | 1.15M |
| Liabilities Non-Current | 2.07M |
| Trade and Non-Trade Payables | 1.39M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 7.59M |
| Net Cash Flow from Financing | 303.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.12M |
| Capital Expenditure | -2.79M |
| Issuance (Purchase) of Equity Shares | 303.00K |
| Net Cash Flow from Investing | -2.79M |
| Net Cash Flow from Operations | -983.00K |
| Effect of Exchange Rate Changes on Cash | 345.00K |
| Share Based Compensation | 2.30M |